Pin-Lan Li Selected Research

Coronary Artery Disease (Coronary Atherosclerosis)

1/2017	Simvastatin promotes NPC1-mediated free cholesterol efflux from lysosomes through CYP7A1/LXRα signalling pathway in oxLDL-loaded macrophages.
1/2016	Lysosomal cholesterol accumulation in macrophages leading to coronary atherosclerosis in CD38(-/-) mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pin-Lan Li Research Topics

Disease

21	Inflammation (Inflammations) 04/2024 - 05/2015
21	Hyperhomocysteinemia 04/2024 - 09/2002
16	Hypoxia (Hypoxemia) 10/2021 - 07/2002
15	Sclerosis 04/2024 - 06/2006
15	Hypertension (High Blood Pressure) 01/2023 - 01/2007
14	Atherosclerosis 12/2022 - 01/2013
11	Obesity 10/2023 - 09/2010
7	Neointima 01/2023 - 05/2014
7	Proteinuria 09/2014 - 04/2010
6	Albuminuria 09/2014 - 10/2011
5	Hypercholesterolemia 12/2022 - 05/2013
5	Infections 01/2021 - 06/2014
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 02/2011
4	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2023 - 01/2020
4	Diabetes Mellitus 01/2022 - 12/2010
3	Neoplasms (Cancer) 01/2022 - 12/2005
3	Vascular Diseases (Vascular Disease) 05/2021 - 02/2015
3	Vascular System Injuries 01/2020 - 05/2010
3	Fibrosis (Cirrhosis) 10/2018 - 06/2013
3	Chronic Renal Insufficiency 04/2018 - 06/2013
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 09/2010
2	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2018
2	Edema (Dropsy) 01/2021 - 06/2015
2	Hyperglycemia 12/2019 - 12/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 01/2016
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 01/2008
2	Liver Cirrhosis (Hepatic Cirrhosis) 06/2016 - 06/2014
2	Arteritis 02/2015 - 05/2014
1	Hyperplasia 01/2023
1	Renovascular Hypertension (Goldblatt Syndrome) 10/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Necrosis 04/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Emphysema 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Anaplasmosis 01/2021
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2021

Drug/Important Bio-Agent (IBA)

39	InflammasomesIBA 04/2024 - 07/2012
17	CeramidesIBA 04/2024 - 09/2009
16	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2002
13	SaltsIBA 01/2023 - 06/2006
10	NucleotidesIBA 10/2023 - 05/2014
10	NLR ProteinsIBA 01/2023 - 07/2012
9	AcidsIBA 04/2024 - 11/2011
9	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 04/2024 - 11/2011
8	Small Interfering RNA (siRNA)IBA 01/2017 - 01/2009
7	SodiumIBA 01/2023 - 11/2012
7	NADPH Oxidases (NAD(P)H oxidase)IBA 09/2014 - 09/2009
6	Superoxides (Superoxide)IBA 12/2022 - 06/2003
6	LipidsIBA 10/2022 - 09/2009
6	SphingolipidsIBA 05/2021 - 09/2010
6	CholesterolIBA 01/2017 - 05/2013
5	EnzymesIBA 10/2023 - 01/2017
5	AdipokinesIBA 01/2019 - 12/2010
5	HomocysteineIBA 01/2016 - 06/2006
4	Acid CeramidaseIBA 01/2023 - 12/2019
4	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 10/2021 - 06/2013
4	Antihypertensive Agents (Antihypertensives)IBA 10/2021 - 01/2007
4	Nicotinamide PhosphoribosyltransferaseIBA 01/2019 - 02/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2018 - 06/2013
4	AlbuminsIBA 11/2017 - 04/2010
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019 - 01/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 01/2013
3	Oxidoreductases (Dehydrogenase)IBA 01/2017 - 06/2013
3	NADP (NADPH)IBA 02/2014 - 01/2009
3	Transcription Factors (Transcription Factor)IBA 01/2014 - 05/2008
2	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2023 - 01/2021
2	Acetates (Acetic Acid Esters)FDA Link 01/2023 - 01/2018
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2023 - 01/2021
2	CollagenIBA 01/2017 - 06/2016
2	Simvastatin (Zocor)FDA LinkGeneric 01/2017 - 01/2013
2	CytokinesIBA 12/2016 - 01/2015
2	EndocannabinoidsIBA 01/2016 - 06/2014
2	oxidized low density lipoproteinIBA 01/2016 - 05/2013
2	NAADP (nicotinic acid adenine dinucleotide phosphate)IBA 01/2016 - 06/2013
2	HMGB1 Protein (HMG1)IBA 12/2015 - 05/2015
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014 - 05/2008
2	Heme Oxygenase-1IBA 01/2014 - 05/2008
2	Cyclic ADP-Ribose (cADPR)IBA 06/2013 - 07/2002
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 05/2013 - 04/2010
2	Death Domain ReceptorsIBA 01/2013 - 05/2010
2	Nitric Oxide Synthase (NO Synthase)IBA 11/2012 - 05/2008
2	Angiotensin IIIBA 10/2011 - 02/2011
2	Hypoxia-Inducible Factor-Proline DioxygenasesIBA 05/2010 - 01/2007
2	Messenger RNA (mRNA)IBA 01/2007 - 06/2006
1	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Annexin A5IBA 01/2022
1	3- (4- chlorophenyl)- adamantane- 1- carboxylic acid (pyridin-4-ylmethyl)amideIBA 01/2022
1	sphingosine kinaseIBA 01/2022
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	Desipramine (Pertofrane)FDA LinkGeneric 01/2021
1	Nonesterified Fatty Acids (NEFA)IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	Pancreatic Elastase (Elastase)IBA 01/2021

Therapy/Procedure

2	Surgical Instruments (Clip) 10/2022 - 05/2014
2	Transplantation 01/2016 - 11/2014
1	Ligation 12/2022
1	Electroacupuncture 01/2021